Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence.
Laura Vera-RamirezSuman K VodnalaRyan NiniKent W HunterJeffrey E GreenPublished in: Nature communications (2018)
Cancer recurrence after initial diagnosis and treatment is a major cause of breast cancer (BC) mortality, which results from the metastatic outbreak of dormant tumour cells. Alterations in the tumour microenvironment can trigger signalling pathways in dormant cells leading to their proliferation. However, processes involved in the initial and the long-term survival of disseminated dormant BC cells remain largely unknown. Here we show that autophagy is a critical mechanism for the survival of disseminated dormant BC cells. Pharmacologic or genetic inhibition of autophagy in dormant BC cells results in significantly decreased cell survival and metastatic burden in mouse and human 3D in vitro and in vivo preclinical models of dormancy. In vivo experiments identify autophagy gene autophagy-related 7 (ATG7) to be essential for autophagy activation. Mechanistically, inhibition of the autophagic flux in dormant BC cells leads to the accumulation of damaged mitochondria and reactive oxygen species (ROS), resulting in cell apoptosis.
Keyphrases
- induced apoptosis
- cell death
- cell cycle arrest
- endoplasmic reticulum stress
- signaling pathway
- squamous cell carcinoma
- reactive oxygen species
- small cell lung cancer
- stem cells
- genome wide
- dna damage
- bone marrow
- young adults
- pi k akt
- breast cancer cells
- mesenchymal stem cells
- dna methylation
- cardiovascular events
- copy number
- free survival
- endoplasmic reticulum